| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Additive manufacturing to fight cancer: Current Applications and Future Directions
|
Duggal, Ishaan
|
|
|
29 |
12 |
p.
|
artikel
|
| 2 |
Advances in, and prospects of, 3D preclinical models for skin drug discovery
|
Imran, Mohammad
|
|
|
29 |
12 |
p.
|
artikel
|
| 3 |
Antibody–drug conjugates: prospects for the next generation
|
Grairi, Meriem
|
|
|
29 |
12 |
p.
|
artikel
|
| 4 |
Beyond CL and VSS: A comprehensive approach to human pharmacokinetic predictions
|
Himstedt, Anneke
|
|
|
29 |
12 |
p.
|
artikel
|
| 5 |
Comprehensive analysis of acetylcholinesterase inhibitor and reactivator complexes: implications for drug design and antidote development
|
Bagrowska, Weronika
|
|
|
29 |
12 |
p.
|
artikel
|
| 6 |
Drugs from drugs: New chemical insights into a mature concept
|
Baró, Eloy Lozano
|
|
|
29 |
12 |
p.
|
artikel
|
| 7 |
Efficacy and challenges involving combination therapies in CLL
|
Alanazi, Majed A.
|
|
|
29 |
12 |
p.
|
artikel
|
| 8 |
Elevating life science R&D success with AI: a framework
|
Sidders, Ben
|
|
|
29 |
12 |
p.
|
artikel
|
| 9 |
Environmental risk assessment in the EU regulation of medicines for human use: an analysis of stakeholder perspectives on its current and future role
|
Zinken, Jim F.
|
|
|
29 |
12 |
p.
|
artikel
|
| 10 |
Ex vivo permeability study of poorly soluble drugs across gastrointestinal membranes: acceptor compartment media composition
|
Sitovs, Andrejs
|
|
|
29 |
12 |
p.
|
artikel
|
| 11 |
Green synthesis of metal nanocarriers: A perspective for targeting glioblastoma
|
Docrat, Taskeen F.
|
|
|
29 |
12 |
p.
|
artikel
|
| 12 |
Heat shock protein 110: A novel candidate for disease diagnosis and targeted therapy
|
Zhao, Congke
|
|
|
29 |
12 |
p.
|
artikel
|
| 13 |
Highlighting roles of autophagy in human diseases: a perspective from single-cell RNA sequencing analyses
|
Khalafiyan, Anis
|
|
|
29 |
12 |
p.
|
artikel
|
| 14 |
How to nurture natural products to create new therapeutics: Strategic innovations and molecule-to-medicinal insights into therapeutic advancements
|
Acharya, Ayan
|
|
|
29 |
12 |
p.
|
artikel
|
| 15 |
Immune safety challenges facing the preclinical assessment and clinical progression of cell therapies
|
Bates, Stephanie M.
|
|
|
29 |
12 |
p.
|
artikel
|
| 16 |
Improving access to domestic innovative medicines: characteristics and trends of approved drugs in China 2010–2024
|
Lan, Yipeng
|
|
|
29 |
12 |
p.
|
artikel
|
| 17 |
Mapping epilepsy biomarkers: a bibliometric and content analysis
|
Ngadimon, Irma Wati
|
|
|
29 |
12 |
p.
|
artikel
|
| 18 |
Metabolic reprogramming in KRAS-mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies
|
Wu, Ruilin
|
|
|
29 |
12 |
p.
|
artikel
|
| 19 |
Peptide-based therapeutics targeting genetic disorders
|
Subramanian, Shweta
|
|
|
29 |
12 |
p.
|
artikel
|
| 20 |
Peptides as innovative strategies to combat drug resistance in cancer therapy
|
Lamb, Henry O.
|
|
|
29 |
12 |
p.
|
artikel
|
| 21 |
Pharma innovation: how evolutionary economics is shaping the future of pharma R&D
|
Schuhmacher, Alexander
|
|
|
29 |
12 |
p.
|
artikel
|
| 22 |
Polybodies: Next-generation clinical antibodies
|
Pande, Abhay H.
|
|
|
29 |
12 |
p.
|
artikel
|
| 23 |
Revisiting the GBB reaction and redefining its relevance in medicinal chemistry: A review
|
Shukla, Pratibha
|
|
|
29 |
12 |
p.
|
artikel
|
| 24 |
Strategic partnerships for AI-driven drug discovery: The role of relational dynamics
|
Kint, Stefan
|
|
|
29 |
12 |
p.
|
artikel
|
| 25 |
The Challenges and Opportunities in Clinical Trial Diversity
|
Bailey, Lisa
|
|
|
29 |
12 |
p.
|
artikel
|
| 26 |
The global status of bioequivalence trials: a comprehensive clinical trial landscape analysis based on the Trialtrove database
|
Zhong, Xiuxin
|
|
|
29 |
12 |
p.
|
artikel
|
| 27 |
The hallmarks of tissue-agnostic therapies and strategies for early anticancer drug discovery
|
Mun, Jihyeob
|
|
|
29 |
12 |
p.
|
artikel
|
| 28 |
The identification of essential cellular genes is critical for validating drug targets
|
Xu, Ting
|
|
|
29 |
12 |
p.
|
artikel
|
| 29 |
Therapeutic development approaches to treat haploinsufficiency diseases: restoring protein levels
|
Evans, Elena F.
|
|
|
29 |
12 |
p.
|
artikel
|
| 30 |
The rejection that defies antirejection drugs—chronic vascular rejection (allograft vasculopathy): The role of terminology and linguistic relativity
|
Subbotin, Vladimir M.
|
|
|
29 |
12 |
p.
|
artikel
|
| 31 |
The Wnt signaling cascade: a potential but untapped therapeutic target for monkeypox infection
|
Faraji, Navid
|
|
|
29 |
12 |
p.
|
artikel
|
| 32 |
Unlocking therapeutic frontiers: harnessing artificial intelligence in drug discovery for neurodegenerative diseases
|
Nehmeh, Bilal
|
|
|
29 |
12 |
p.
|
artikel
|
Tijdschrift beschrijving